Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti-Mtb Gyrase Activity

New antitubercular agents with either a novel mode of action or novel mode of inhibition are urgently needed to overcome the threat of drug-resistant tuberculosis (TB). The present study profiles new arylated quinoline carboxylic acids (QCAs) having activity against replicating and non-replicating M...

Descripción completa

Detalles Bibliográficos
Autores principales: Quimque, Mark Tristan J., Go, Adrian D., Lim, Justin Allen K., Vidar, Warren S., Macabeo, Allan Patrick G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380224/
https://www.ncbi.nlm.nih.gov/pubmed/37511390
http://dx.doi.org/10.3390/ijms241411632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380224/
https://www.ncbi.nlm.nih.gov/pubmed/37511390
http://dx.doi.org/10.3390/ijms241411632

Ejemplares similares